Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Mouse Models of Cancer: understand their limitations to exploit their strengths

With Dr Jane Kendrew, Director of Translational Oncology

Oncology disease models have not always had great press, but they remain a critical part of the drug discovery process. There are limitations in any animal model of disease, but with the right questions, the right understanding and the right interpretation, these models can add tremendous strength and value to drug discovery projects.

View Webinar

Webinar Data Capture

Latest Webinars

View All

Mouse Models of Cancer: understand their limitations…

To Control or be Controlled: Navigating the…

How DMPK should integrate with and influence…

Rethinking Diabetes Drug Discovery

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.